| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 4 | 13 | -1,77 % | ||
| REVOLUTION MEDICINES | 4 | 5 | +0,99 % | ||
| AMGEN | 2 | 27 | +0,13 % | ||
| XENON PHARMACEUTICALS | 2 | - | 0,00 % | ||
| DEFINIUM THERAPEUTICS | 2 | - | +17,62 % | ||
| TRAVERE THERAPEUTICS | 1 | 11 | -1,15 % | ||
| NOVAVAX | 1 | 7 | -0,93 % | ||
| ZAI LAB LTD ADR | 1 | 6 | +1,96 % | ||
| GRIFOLS | 1 | 4 | -4,00 % | ||
| RECURSION PHARMACEUTICALS | 1 | 3 | 0,00 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:30 | Curevac unter der Lupe: Was große Adressen heute bereits wissen - Verpassen Sie das nicht | Hebelschein-Spekulant | |||
| 09:22 | XFRA A71: AUSSETZUNG/SUSPENSION | 26 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILASCENDIS PH.SP.ADR... ► Artikel lesen | |
| 09:14 | Biontech SE ADR - Bewegung mit Substanzbedarf | 20 | Maximilian Berger | ||
| 09:12 | Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP | 8 | Seeking Alpha | ||
| 08:15 | NASDAQ, Washington, Psychedelika - und Optimi steht im Zentrum der Explosion | Suneal Sandhu | |||
| 05:46 | Insiderverkäufe, Kaufempfehlungen und KI-Fantasie: BioNTech, Evotec, Vidac Pharma Aktie. | 934 | ESG-Aktien.de | Insiderverkäufe bei Vidac Pharma. Dies ist jedoch kein Alarmsignal, sondern bietet eher eine Einstiegschance. Das Unternehmen arbeitet an einer revolutionären Krebstherapie. In 2026 sollen wichtige... ► Artikel lesen | |
| 04:26 | Revolution Medicines (RVMD) Jumps 54% on Stellar Drug Trial Results | 5 | Insider Monkey | ||
| 00:30 | Xenon Pharma's azetukalner shows 53% seizure reduction in trial | 1 | Investing.com | ||
| 00:26 | Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership | 8 | Insider Monkey | ||
| 00:26 | Here's What TD Cowen Thinks About Tempus AI Inc (TEM) Stock | 8 | Insider Monkey | ||
| 00:06 | Xenon Pharmaceuticals Inc.: Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting | 48 | GlobeNewswire (Europe) | Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time pointsX-TOLE2 data featured in Late-breaking Science session show 53.2% reduction in monthly... ► Artikel lesen | |
| 00:06 | Immunocore Holdings plc: KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A02:01+ patients with metastatic uveal melanoma | 41 | GlobeNewswire (Europe) | KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma OS benefit observed across key subgroups, including patients with... ► Artikel lesen | |
| So | Is Shah Capital's Criticism of Novavax Fair? A Wall Street Analyst Weighs In | 7 | MedCity News | ||
| So | Amneal rated Buy in new research coverage at UBS as growth pipeline expands | 4 | Seeking Alpha | ||
| So | Mesoblast Limited (MESO), One of the Best Long-Term ASX Stocks To Buy Right Now; See Why | 2 | Insider Monkey | ||
| So | Revolution Medicines: Starke Phase-1-Daten für Lungenkrebsmedikament treiben Aktie an | 8 | Investing.com Deutsch | ||
| So | Revolution Medicines, Inc.: Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting | 5 | GlobeNewswire (USA) | ||
| So | Revolution Medicines reports phase 1 data for lung cancer drug | 3 | Investing.com | ||
| So | Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy | 6 | Insider Monkey | ||
| So | Grifols (GRFS) Unveils AI-Driven Data for Early Parkinson's Disease Detection | 9 | Insider Monkey |